     |
 |
Latest Personal Injury News Vioxx® Withdrawn from the Market
Source:
September 30, 2004
New York: Merck & Co. has pulled it arthritis drug Vioxx from the marketplace today. According to the company, Vioxx has been linked to an increase of heart attacks and strokes in patients, and due to the availability of alternative therapies, it should be withdrawn. The long-standing concerns for Vioxx and its heart and stroke-related side effects were confirmed in a clinical trial of colon cancer patients. Since the announcement, the FDA has announced that it will closely watch other drugs of the same Cox-2 inhibitor family (Celebrex and Bextra). Total sales of Vioxx las year reached $2.55 billion. Since the drug was introduced in 1999, over 90 million prescriptions have been written. << Back to News |